ABBVIE INCABBVIE INCABBVIE INC

ABBVIE INC

Tidak ada perdagangan
Lihat pada chart super

Obligasi 4AB

Berikut ini adalah daftar obligasi korporasi ABBVIE INC. Investor sering memilih obligasi perusahaan karena stabilitasnya yang lebih baik di saat pasar bergejolak. Pelajari harga, imbal hasil, dan statistik mereka lainnya dan temukan investasi yang dapat diandalkan.
Simbol
YTM %
Volume
Harga %
Kupon %
Tanggal Jatuh Tempo
Jumlah yang belum dibayar
Nilai nominal
Jumlah denominasi minimum
Penerbit
AA5QDALLERGAN FNDG 15/25
9,42%099,77%3,80%2025-03-15130,22 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
8,14%50 K74,10%4,75%2045-03-1553,51 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
7,72%24 K76,91%4,63%2042-10-0167,49 M USD1.000,00 USD2.000,00 USDActavis, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
7,69%15 K77,85%4,85%2044-06-1565,23 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
6,67%600 K87,27%4,55%2035-03-15107,65 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
6,17%3,13 M99,90%3,80%2025-03-152,89 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,79%30,55 M84,35%4,25%2049-11-215,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,75%235 K90,14%4,63%2042-10-01389,22 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,74%26 K90,47%3,20%2029-11-2162,52 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5,69%088,11%4,45%2046-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5,62%091,30%4,70%2045-05-142,7 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,57%166 K92,23%4,75%2045-03-15827,09 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABCABBVIE 15/25
5,57%099,60%3,60%2025-05-143,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5,56%55 K89,69%4,40%2042-11-062,6 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,54%80 K93,14%4,88%2048-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,54%6,24 M99,56%5,50%2064-03-151,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,50%3,49 M88,22%4,05%2039-11-214 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,47%5 K94,16%4,85%2044-06-151,01 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,40%4,58 M100,00%5,40%2054-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
5,35%38,73 M102,83%5,60%2055-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,29%426 K100,60%5,35%2044-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5,20%093,62%4,30%2036-05-141 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5,10%096,00%4,50%2035-05-142,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5,07%504 K96,54%4,55%2035-03-151,68 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
4,91%10,6 M101,96%5,20%2035-03-151 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4,90%5,1 M100,95%5,05%2034-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,70%7,05 M94,20%3,20%2029-11-215,44 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,62%5,39 M101,56%4,95%2031-03-152 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
4,55%13,45 M101,35%4,88%2030-03-151 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4,50%1,27 M101,03%4,80%2029-03-152,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,42%098,60%3,20%2026-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4,41%4,38 M97,65%2,95%2026-11-213,99 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
4,39%1,1 M100,70%4,65%2028-03-151,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4,39%1,01 M99,57%4,25%2028-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4,33%770 K100,88%4,80%2027-03-152,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
4,11%095,21%2,63%2028-11-1572,11 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
XXS162262122ALLERGAN FNDG 17/29
4,07%092,96%2,13%2029-06-0136,46 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
3,86%096,53%2,95%2026-11-219,24 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
3,01%0102,15%3,80%2025-03-151,27 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2,97%090,37%1,25%2031-11-18650 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
2,90%0121,31%4,25%2049-11-214,95 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
2,88%0126,76%4,75%2045-03-155 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,83%0128,71%4,85%2044-06-15100 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS212591491ABBVIE 20/29
2,77%097,56%2,13%2029-06-01506,09 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2,71%098,03%2,13%2028-11-17750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2,70%099,76%2,63%2028-11-15427,79 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2,55%095,41%0,75%2027-11-18750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,35%0123,74%4,55%2035-03-151 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
3,80%2025-03-151.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
4,40%2042-11-061,1 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.